Bio-thera Solutions
Clinical trials sponsored by Bio-thera Solutions, explained in plain language.
-
New injection aims to stop Flare-Ups in rare autoimmune disease
Disease control OngoingThis study tests a new medicine called BAT4406F in people with neuromyelitis optica spectrum disorder (NMOSD), a rare disease where the immune system attacks the nerves in the eyes and spinal cord. The trial includes 162 adults who have had recent relapses and test positive for a…
Phase: PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New drug duo targets advanced cancers in early trial
Disease control OngoingThis study tests whether combining two experimental drugs, BAT8008 and BAT1308, is safe and effective for people with advanced solid tumors that have not responded to standard treatments. About 112 adults will take part, first to find the best dose and then to see how well the dr…
Phase: PHASE1, PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC